Opioids, Reward and Addiction: An Encounter of Biology ...

394 VAN REE ET AL.
on the acquisition of self-injection of heroin under schedule and non schedule
conditions in rats. Pharmacol Biochem Behav 20:807–809.
Singh J, Desiraju T, Nagaraja TN and Raju TR (1994) Facilitation of self-stimulation
of ventral tegmentum by microinjection of opioid receptor subtype agonists.
Physiol Behav 55:627–631.
Singh L, Field MJ, Hunter JC, Oles RJ and Woodruff GN (1996a) Modulation of the
in vivo actions of morphine by the mixed CCKA/B receptor antagonist PD 142898.
Eur J Pharmacol 307:283–289.
Singh L, Oles RJ, Field MJ, Atwal P, Woodruff GN and Hunter JC (1996b) Effect of
CCK receptor antagonists on the antinociceptive, reinforcing and gut motility
properties of morphine. Br J Pharmacol 118:1317–1325.
Singh NA, Midgley LP, Bush LG, Gibb JW and Hanson GR (1991) N-methyl-Daspartate
receptors mediate dopamine-induced changes in extrapyramidal and
limbic dynorphin systems. Brain Res 555:233–238.
Sivam SP (1989) Cocaine selectively increases striatonigral dynorphin levels by a
dopaminergic mechanism. J Pharmacol Exp Ther 250:818–824.
Skinner BF (1938) The Behavior of Organisms, Appleton-Century Crofts, New York.
Slifer BL and Balster RL (1983) Reinforcing properties of stereoisomers of the
putative “sigma”-agonists N-allylnormetazocine and cyclazocine in rhesus monkeys.
J Pharmacol Exp Ther 225:522–528.
Smiley PL, Johnson M, Bush L, Gibb JW and Hanson GR (1990) Effects of cocaine on
extrapyramidal and limbic dynorphin systems. J Pharmacol Exp Ther 253:938–
943.
Smith AJW and McGinty JF (1994) Acute amphetamine and metamphetamine alter
opioid peptide mRNA expression in the rat striatum. Mol Brain Res 21:359–362.
Smith BR, Brown ZW and Amit Z (1982) Intraventricular self-administration of
leucine-enkephalin by laboratory rats. Life Sci 31:1527–1530.
Smith JE, Co C, Freeman ME, Sands MP and Lane JD (1980) Neurotransmitter
turnover in rat striatum is correlated with morphine self-administration. Nature
(Lond) 287:152–153.
Smith JE, Co C and Lane JD (1984) Limbic acetylcholine turnover rates correlated
with rat morphine-seeking behaviours. Pharmacol Biochem Behav 20:429–442.
Smith JE, Geurin GF, Co C, Barr TS and Lane JD (1985) Effects of 6-OHDA lesions
of the medial nucleus accumbens on rat intravenous morphine self-administration.
Pharmacol Biochem Behav 23:843–849.
Smith JE, Shultz K, Co C, Goeders NE and Dworkin SI (1987) Effects of 5,7
dihydroxytryptamine lesions of the nucleus accumbens on rat intravenous morphine
self-administration. Pharmacol Biochem Behav 26:607–612.
Smith SG and Davis WM (1974) Intravenous alcohol self-administration in the rat.
Pharmacol Res Commun 4:397–401.
Smith SG, Werner TE and Davis WM (1976) Effect of unit dose and route of
administration on self-administration of morphine. Psychopharmacology 50:103–
105.
Solomon RE (1980) The opponent theory of acquired motivation. Am Psychol 35:691–
712.
Spanagel R (1995) Modulation of drug-induced sensitization processes by endogenous
opioid systems. Behav Brain Res 70:37–49.
Spanagel R, Almeida OF, Bartl C and Shippenberg TS (1994) Endogenous -opioid
systems in opiate withdrawal: role in aversion and accompanying changes in
mesolimbic dopamine release. Psychopharmacology 115:121–127.
Spanagel R, Herz A, Bals-Kubik R and Shippenberg TS (1991) -Endorphin-induced
locomotor stimulation and reinforcement are associated with an increase in dopamine
release in the nucleus accumbens. Psychopharmacology 104:51–56.
Spangler R, Zhou Y, Maggos CE, Schlussman SD, Ho A and Kreek MJ (1997)
Prodynorphin, proenkephalin and -opioid receptor mRNA responses to acute
’binge’ cocaine. Mol Brain Res 44:139–142.
Spanagel R and Zieglgänsberger W (1997) Anti-craving compounds for ethanol: New
pharmacological tools to study addictive processes. Trends Pharmacol Sci 18:54–
59.
Spragg SDS (1940) Morphine addiction in chimpanzees. Comp Psychol Monogr
15:1–132.
Spyraki C, Fibiger HC and Phillips AG (1983) Attenuation of heroin reward in rats
by disruption of the mesolimbic dopamine system. Psychopharmacology 79:278–
283.
Spyraki C, Nomikos GG, Galanopoulou P and Daifotis Z (1988) Drug-induced place
preference in rats with 5,7-dihydroxytryptamine lesions of the nucleus accumbens.
Behav Brain Res 29:127–134.
Staley JK, Rothman RB, Rice KC, Partilla J and Mash DC (1997) Kappa-2 opioid
receptors in limbic areas of the human brain are upregulated by cocaine in fatal
overdose victims. J Neurosci 17:8225–8233.
Stein EA (1993) Ventral tegmental self-stimulation selectively induces opioid peptide
release in rat CNS. Synapse 13:63–73.
Stein EA and Olds J (1977) Direct intracerebral self-administration of opiates in
rats. Soc Neurosci Abst 3:302.
Stein EA and Zirneskie J (1979) Is reward behaviour mediated by an endogenous
opiate system. Soc Neurosci Abst 5:573.
Stein L and Belluzzi JD (1978) Brain endorphins and the sense of well-being: A
psychobiological hypothesis. Adv Biochem Psychopharmacol 18:299–311.
Stein L and Ray OS (1960) Brain stimulation reward “thresholds” selfdetermined in
rat. Psychopharmacologia 1:251–256.
Steiner H and Gerfen CR (1993) Cocaine-induced c-fos messenger RNA is inversely
related to dynorphin expression in striatum. J Neurosci 13:5066–5081.
Steinfels GF, Young GA and Khazan N (1982) Self-administration of nalbuphine,
butorphanol and pentazocine by morphine post-addict rats. Pharmacol Biochem
Behav 16:167–171.
Steinpreis RE, Rutell AL and Parrett FA (1996) Methadone produces conditioned
place preference in the rat. Pharmacol Biochem Behav 54:339–341.
Stevens KE, Shiotsu G and Stein L (1991) Hippocampal -receptors mediate opioid
reinforcement in the CA3 region. Brain Res 545:8–16.
Stewart J (1983) Conditioned and unconditioned drug effects in relapse to opiate and
stimulant drug self-adminstration. Prog Neuropsychopharmacol Biol Psychiatry
7:591–597.
Stewart J (1984) Reinstatement of heroin and cocaine self-administration behavior
in the rat by intracerebral application of morphine in the ventral tegmental area.
Pharmacol Biochem Behav 20:917–923.
Stewart J and Badiani A (1993) Tolerance and sensitization to the behavioral effects
of drugs. Behav Pharmacol 4:289–312.
Stewart J, De Wit H and Eikelboom R (1984) Role of unconditioned and conditioned
drug effects in the self-administration of opiates and stimulants. Psychol Rev
91:251–268.
Stewart J and Vezina P (1988) A comparison of the effects of intra-accumbens
injections of amphetamine and morphine on reinstatement of heroin intravenous
self-administration behavior. Brain Res 457:287–294.
Stewart J and Wise RA (1992) Reinstatement of heroin self-administration habits:
Morphine prompts and naltrexone discourages renewed responding after extinction.
Psychopharmacology 108:79–84.
Stinus L, Le Moal M and Koob GF (1990) Nucleus accumbens and amygdala are
possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience
37:767–773.
Stinus L, Nadaud D, Deminiere JM, Jauregui J, Hand TT and Le Moal M (1989)
Chronic flupentixol treatment potentiates the reinforcing properties of systemic
heroin administration. Biol Psychiatry 26:363–371.
Strain EC, Preston KL, Liebson IA and Bigelow GE (1996a) Opioid antagonist effects
of dezocine in opioid-dependent humans. Clin Pharmacol Ther 60:206–217.
Strain EC, Stitzer ML, Liebson IA and Bigelow GE (1996b) Buprenorphine versus
methadone in the treatment of opioid dependence: self-reports, urinalysis, and
addiction severity index. J Clin Psychopharmacol 16:58–67.
Stromberg MF, Casale M, Volpicelli L, Volpicelli JR and O’Brien CP (1998) A
comparison of the effects of the opioid antagonists naltrexone, naltrindole and
-funaltrexamine on ethanol consumption in the rat. Alcohol 15:281–289.
Stutz RM, Maroli AN, Tsang WK and Harvan PA (1980) Facilitation of selfstimulation
in rats by methadone. Pharmacol Biochem Behav 13:919–924.
Suzuki T, Funada M, Narita M, Misawa M and Nagase H (1991) Pertussis toxin
abolishes - and -opioid agonist-induced place preference. Eur J Pharmacol
205:85–88.
Suzuki T, George FR and Meisch RA (1992a) Etonitazene delivered orally serves as
a reinforcer for Lewis but not Fischer 344 rats. Pharmacol Biochem Behav 42:
579–586.
Suzuki T, Funada M, Narita M, Misawa M and Nagase H (1993) Morphine-induced
place preference in the CXBK mouse: Characteristics of -opioid receptor subtypes.
Brain Res 602:45–52.
Suzuki T, Ikeda H, Tsuji M, Misawa M, Narita M and Tseng LF (1997a) Antisense
oligodeoxynucleotide to opioid receptors attenuates morphine dependence in
mice. Life Sci 61:PL165-PL170.
Suzuki T, Kishimoto Y and Misawa M (1996a) Formalin- and carrageenan-induced
inflammation attenuates place preferences produced by morphine, methamphetamine
and cocaine. Life Sci 59:1667–1674.
Suzuki T, Mori T, Tsuji M, Misawa M and Nagase H (1994a) The role of -opioid
receptor subtypes in cocaine- and methamphetamine-induced place preferences.
Life Sci 55:PL339–PL344.
Suzuki T, Shiozaki Y, Masukawa Y, Misawa M and Nagase H (1992b) The role of and
-opioid receptors in cocaine-induced conditioned place preference. Jpn
J Pharmacol 58:435–442.
Suzuki T, Sugano Y, Funada M and Misawa M (1995a) Adrenalectomy potentiates
the morphine- but not cocaine-induced place preference in rats. Life Sci 56:PL339–
PL344.
Suzuki T, Takamori K, Misawa M and Onodera K (1995b) Effects of the histaminergic
system on the morphine-induced conditioned place preference in mice. Brain
Res 675:195–202.
Suzuki T, Tsuda M, Funada M and Misawa M (1995c) Blockade of morphine-induced
place preference by diazepam in mice. Eur J Pharmacol 280:327–330.
Suzuki T, Tsuji M, Ikeda H, Narita M and Tseng LF (1997b) Antisense oligodeoxynucleotide
to delta opioid receptors blocks cocaine-induced place preference in
mice. Life Sci 60:PL283–PL288.
Suzuki T, Tsuji M, Mori T, Ikeda H, Misawa M and Nagase H (1997c) Involvement
of dopamine-dependent and -independent mechanisms in the rewarding effects
mediated by -opioid receptor subtypes in mice. Brain Res 744:327–334.
Suzuki T, Tsuji M, Mori T, Misawa M, Endoh T and Nagase H (1996b) Effect of the
highly selective and nonpeptide -opioid receptor agonist TAN-67 on the morphine-induced
place preference in mice. J Pharmacol Exp Ther 279:177–185.
Suzuki T, Tsuji M, Mori T, Misawa M and Nagase H (1996c) The effects of dopamine
D-1 and D-2 receptor antagonists on the rewarding effects of (1) and (2) opioid
receptor agonists in mice. Psychopharmacology 124:211–218.
Suzuki T, Yoshiike M, Mizoguchi H, Kamei J, Misawa M and Nagase H (1994b)
Blockade of -opioid receptors prevents morphine-induced place preference in
mice. Jpn J Pharmacol 66:131–137.
Sweep CG, Van Ree JM and Wiegant VM (1988) Characterization of -endorphinimmunoreactivity
in limbic brain structures of rats self-administering heroin or
cocaine. Neuropeptides 12:229–236.
Sweep CG, Wiegant VM, De Vry J and Van Ree JM (1989) Beta-endorphin in brain
limbic structures as neurochemical correlate of psychic dependence on drugs. Life
Sci 44:1133–1140.
Swift RM (1995) Effect of naltrexone on human alcohol consumption. J Clin Psychiatry
56:24–29.
Tabakoff B, Hellevuo K and Hoffmann PL (1996) Alcohol, in Pharmacological Aspects
of Drug Dependence (Schuster CR and Kuhar MJ eds) pp 374–460, Springer-
Verlag, Berlin.
Takahashi H, Singer G and Oei TP (1978) Schedule-induced self-injection of damphetamine
by naive animals. Pharmacol Biochem Behav 9:857–861.
Takahashi RN and Singer G (1979) Self-administration of 9 -tetrahydrocannabinol
by rats. Pharmacol Biochem Behav 11:737–740.